Resources

Could this be in store for the U.S. and other countries?

After 16 weeks of treatment, mean reductions of HbA1c were -1.6% for the repaglinide group and -1.0% for the nateglinide group.

Rofecoxib significantly increased systolic blood pressure, while celecoxib (Celebrex) and naproxen did not.

ACE-inhibitors or calcium antagonists may be better choices.

Diabetic patients demonstrate and interaction between level of fasting glycemia, lung function and any past or present tobacco smoking.

Thiazolidinedione-induced fluid retention in diabetics with chronic systolic heart failure (HF) is likely to be peripheral and reversible after drug withdrawal

Every year, more than 330,000 people die in the region of the Americas due to causes related to diabetes. Diabetes affects approximately 28 million people in the region One of the most serious problems in Latin America and the Caribbean, both in terms of public health and economic burden, is …

New findings in mice suggest that skipping the occasional meal may be good for your health.

A drop in A1c has a corresponding rise in HDL.

Rofecoxib significantly increased systolic blood pressure, while celecoxib (Celebrex) and naproxen did not.